Pharmacogenomics is the study of how a person's genes affect how he or she responds to medication. As the field expands, it may have a significant impact on the future of drug development. Darshan discusses how pharmacogenomic testing may lead to changes in FDA regulatory guidelines. Also, how pharmaceutical companies are beginning to rethink the drug development process.